Authors:
HEEREMANS JLM
PREVOST R
FEITSMA H
KLUFT C
CROMMELIN DJA
Citation: Jlm. Heeremans et al., CLOT ACCUMULATION CHARACTERISTICS OF PLASMINOGEN-BEARING LIPOSOMES INA FLOW-SYSTEM, Thrombosis and haemostasis, 79(1), 1998, pp. 144-149
Authors:
LAVERMAN P
DAMS ETM
OYEN WJG
STORM G
KOENDERS EB
PREVOST R
CORSTENS FHM
BOERMAN OC
Citation: P. Laverman et al., A NOVEL METHOD TO LABEL LIPOSOMES WITH TC-99M VIA THE HYDRAZINO NICOTINYL DERIVATIVE, The Journal of nuclear medicine, 39(5), 1998, pp. 18-18
Authors:
HEEREMANS JLM
MIJNHEER FW
GERRITSEN HR
PREVOST R
KLUFT C
CROMMELIN DJA
Citation: Jlm. Heeremans et al., LONG-TERM STABILITY OF LIPOSOMES CONTAINING BOTH TISSUE-TYPE PLASMINOGEN-ACTIVATOR AND GLU-PLASMINOGEN, International journal of pharmaceutics, 129(1-2), 1996, pp. 191-202
Authors:
ANDREOTTI F
PREVOST R
LUPI A
HAMILTON J
DEBART ACW
HUISMAN LGM
MASERI A
KLUFT C
Citation: F. Andreotti et al., CIRCADIAN PATTERNS OF PLASMA T-PA AND PAI-1 ANTIGEN LEVELS IN PATIENTS WITH SEVERE PERIPHERAL ATHEROSCLEROSIS, Fibrinolysis, 10, 1996, pp. 159-160
Authors:
HEEREMANS JLM
GERRITSEN HR
MEUSEN SP
MIJNHEER RW
PANDAY RSG
PREVOST R
KLUFT C
CROMMELIN DJA
Citation: Jlm. Heeremans et al., THE PREPARATION OF TISSUE-TYPE PLASMINOGEN-ACTIVATOR (T-PA) CONTAINING LIPOSOMES - ENTRAPMENT EFFICIENCY AND ULTRACENTRIFUGATION DAMAGE, Journal of drug targeting., 3(4), 1995, pp. 301-310
Authors:
HEEREMANS JLM
PREVOST R
BEKKERS MEA
LOS P
EMEIS JJ
KLUFT C
CROMMELIN DJA
Citation: Jlm. Heeremans et al., THROMBOLYTIC TREATMENT WITH TISSUE-TYPE PLASMINOGEN-ACTIVATOR (T-PA) CONTAINING LIPOSOMES IN RABBITS - A COMPARISON WITH FREE T-PA, Thrombosis and haemostasis, 73(3), 1995, pp. 488-494
Authors:
HEEREMANS JLM
PREVOST R
BISCHOT L
LOS P
KLUFT C
CROMMELIN DJA
Citation: Jlm. Heeremans et al., INTERFERENCE OF EPSILON-AMINO-CAPROIC ACID WITH [N-SUCCINIMIDYL S-ACETYLTHIOACETATE DERIVED] THIOL-INTRODUCTION INTO GLU-PLASMINOGEN, Fibrinolysis, 8, 1994, pp. 138-141